KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to 0.29%.

  • Teva Pharmaceutical Industries' Return on Invested Capital rose 4000.0% to 0.29% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.29%, marking a year-over-year increase of 4000.0%. This contributed to the annual value of 0.29% for FY2025, which is 3500.0% up from last year.
  • As of Q4 2025, Teva Pharmaceutical Industries' Return on Invested Capital stood at 0.29%, which was up 4000.0% from 0.18% recorded in Q3 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Return on Invested Capital peaked at 0.29% during Q2 2025, and registered a low of 0.24% during Q1 2021.
  • Its 5-year average for Return on Invested Capital is 0.01%, with a median of 0.03% in 2024.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Return on Invested Capital tumbled by -2400bps in 2022 and then skyrocketed by 4000bps in 2025.
  • Teva Pharmaceutical Industries' Return on Invested Capital (Quarter) stood at 0.09% in 2021, then plummeted by -275bps to 0.15% in 2022, then skyrocketed by 130bps to 0.05% in 2023, then tumbled by -338bps to 0.11% in 2024, then skyrocketed by 359bps to 0.29% in 2025.
  • Its Return on Invested Capital was 0.29% in Q4 2025, compared to 0.18% in Q3 2025 and 0.29% in Q2 2025.